Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Nature Communications|January 21, 2026
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trialXiaobin Zheng, Huashan Liu, Lishuo Shi, et al.Digestive Diseases and Sciences|June 15, 2014
Molecular mechanism of acute radiation enteritis revealed using proteomics and biological signaling network analysis in ratsShunxin Song, Dianke Chen, Tenghui Ma, et al.Surgery|May 15, 2025
Risk assessment of lymph node metastasis in early gastric cancer patients with vagus nerve-preserving gastrectomy: A multiple centers potential analysis in ChinaXinyu Wang, Xiangyu Wang, Qi You, et al.Journal of Translational Medicine|June 19, 2023
Induction of filopodia formation by α-Actinin-2 via RelA with a feedforward activation loop promoting overt bone marrow metastasis of gastric cancerCaiqin Wang, Bo Xie, Shi Yin, et al.International Journal of General Medicine|May 19, 2026
Restaging pN Classification in Early Gastric Cancer with Inadequate Lymph Node Retrieval: Multi-Institutional Development and Prognostic Validation of a Revised Staging SystemXinyang Nie, Gang Li, Zhiqiang Liu, et al.International Journal of Surgery (London, England)|April 23, 2025
Artificial neural network model enhancing the accuracy of clinical evaluation for high-risk population of lymph node metastasis in non-intestinal type early gastric cancer: a multicenter real-world study in ChinaJiamei Guo, Kecheng Zhang, Gang Ji, et al.Annals of Surgery|July 11, 2022
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled TrialHuashan Liu, Ziwei Zeng, Hong Zhang, et al.JAMA|January 23, 2025
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical TrialZiwei Zeng, Shuangling Luo, Hong Zhang, et al.International Journal of Surgery (London, England)|February 13, 2024
Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trialYaoyi Huang, Yumo Xie, Puning Wang, et al.The Lancet. Oncology|July 1, 2026
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trialHuabin Hu, Xutao Shen, Yunfeng Li, et al.Pageof 6